Public Health Agency of Canada
Symbol of the Government of Canada

Share this page

ARCHIVED - Guidelines for the Prevention and Control of Meningococcal Disease

Warning This page has been archived.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of CanadaExternal link, you can request alternate formats on the "Contact Us" page.

Supplement

May 2005

Volume 31S1

Guidelines for the Prevention and Control of Meningococcal Disease
(PDF document 752.85 KB - 26 pages)

» How to download PDF documents

Addendum:
Updated 15 November 2006:
Guidelines for the Prevention and Control of meningococcal Disease


Contained in this issue:

Table of Contents

1.0 Introduction

2.0 Objectives

3.0 Epidemiology of Invasive Meningococcal Disease in Canada

4.0 Definitions

  • 4.1 National Case Definition
  • 4.2 Definitions for Public Health Management
    • 4.2.1 Cases and Contacts
    • 4.2.2 Outbreaks
    • 4.2.3 Persistently Elevated Rates

5.0 Diagnosis and Bacterial Typing

6.0 Surveillance of Invasive Meningococcal Disease in Canada

7.0 Management of Invasive Meningococcal Disease

  • 7.1 Management of Sporadic Cases
    • 7.1.1 Case Management
    • 7.1.2 Contact Management
    • 7.1.3 Cadavers and Infectious Risk
    • 7.1.4 Invasive Meningococcal Disease in Travellers
  • 7.2 Detection and Management of Outbreaks
  • 7.3 Management of Persistently Elevated Rate of Meningococcal Disease

8.0 Communication Strategies

  • 8.1 Communication Pertaining to Sporadic Cases
  • 8.2 Communication Pertaining to Outbreaks
  • 8.3 Communication Pertaining to Persistently Elevated Rates

9.0 Recommendations for Travellers

  • 9.1 Travellers to Destinations within Canada
  • 9.2 Students Attending Colleges in the United States
  • 9.3 Travellers to International Destinations 9.4 International Travellers Arriving in Canada

10.0 Recommendations for Chemoprophylaxis

11.0 Indications For and Use of Meningococcal Vaccines

  • 11.1 Close Contacts
  • 11.2 Outbreaks
  • 11.3 Revaccination

Appendix 1: Persons involved in Guideline Development and Review

References

Suggested citation: Public Health Agency of Canada. Guidelines for the Prevention and Control of Meningococcal Disease. CCDR 2005;31S1:1-20.

This publication was produced by the Scientific Publication and Multimedia Services Section of the Communications Directorate.

To obtain additional copies or subscribe to the Canada Communicable Disease Report, please contact the Member Service Centre, Canadian Medical Association, 1867 Alta Vista Drive, Ottawa, ON, Canada K1G 3Y6, Tel.: (613) 731-8610 Ext. 2307 or 888-855-2555 or by Fax: (613) 236-8864.

© Her Majesty the Queen in Right of Canada, represented by the Minister of Health (2005)